Načítá se...
Blocking the Leukotriene B4 Receptor 1 Inhibits Late-Phase Airway Responses in Established Disease
Most of the studies investigating the effectiveness of blocking the leukotriene B4 (LTB4) receptor 1 (BLT1) have been performed in models of primary or acute allergen challenge. The role of the LTB4-BLT1 pathway in secondary challenge models, where airway hyperresponsiveness (AHR) and airway inflamm...
Uloženo v:
Hlavní autoři: | , , , , , , , , , , |
---|---|
Médium: | Artigo |
Jazyk: | Inglês |
Vydáno: |
American Thoracic Society
2011
|
Témata: | |
On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3208610/ https://ncbi.nlm.nih.gov/pubmed/21421908 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1165/rcmb.2010-0455OC |
Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|